Active Ingredient Ofatumumab
Active Ingredient Details
What is the usage for Ofatumumab?
Ofatumumab is used to treat a certain type of cancer (chronic lymphocytic leukemia - CLL). Ofatumumab belongs to a class of drugs known as monoclonal antibodies. This medication works by stopping the growth of cancer cells.
How many products in the NDC database contain Ofatumumab?
The NDC database has 4 products with the active ingredient Ofatumumab. The following table lists all the products that have this active ingredient.
NDC Products with Ofatumumab
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
|---|---|---|---|---|---|---|---|
| 0078-0669 | Proprietary Name: Arzerra | Ofatumumab | Injection, Solution | Intravenous | Novartis Pharmaceuticals Corporation | ACTIVE | |
| 0078-0690 | Proprietary Name: Arzerra | Ofatumumab | Injection, Solution | Intravenous | Novartis Pharmaceuticals Corporation | ACTIVE | |
| 0078-1007 | Proprietary Name: Kesimpta | Ofatumumab | Injection, Solution | Subcutaneous | Novartis Pharmaceuticals Corporation | ACTIVE | |
| 67643-0016 | Proprietary Name: | Ofatumumab | Liquid | Lonza Biologics Inc. | ACTIVE |